Cardiovascular responses to microinjections of urocortin 3 into the nucleus tractus solitarius of the rat

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 296, Issue 2, 2009, Pages

  Nakamura, Takeshi ^a   Kawabe, Kazumi ^a   Sapru, Hreday N ^a,b  

^a RWJ Barnabas Health   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Blood pressure; Corticotropin releasing factor receptor antagonists; Heart rate; Nucleus tractus solitarius; Sympathetic nerve activity; Urocortin

Indexed keywords

ASTRESSIN; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; URETHAN; UROCORTIN III; AMPHIBIAN PROTEIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CRF RECEPTOR TYPE 2; PEPTIDE FRAGMENT; PEPTIDE HORMONE; SAUVAGINE; UROCORTIN;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; BRADYCARDIA; CARDIOVASCULAR RESPONSE; CEREBROSPINAL FLUID; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DECEREBRATION; EFFERENT NERVE; HEART RATE; MALE; MEAN ARTERIAL PRESSURE; MICROINJECTION; NERVE CONDUCTION; NERVE EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SOLITARY TRACT NUCLEUS; SPLANCHNIC NERVE; SYMPATHETIC NERVE; VAGOTOMY; WISTAR RAT; ANIMAL; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; GENERAL ANESTHESIA; HEART; HYPOTENSION; INNERVATION; METABOLISM; PATHOPHYSIOLOGY;

AMPHIBIAN PROTEINS; ANESTHESIA, GENERAL; ANIMALS; BLOOD PRESSURE; BRADYCARDIA; CORTICOTROPIN-RELEASING HORMONE; DECEREBRATE STATE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART; HEART RATE; HYPOTENSION; MALE; MICROINJECTIONS; PEPTIDE FRAGMENTS; PEPTIDE HORMONES; RATS; RATS, WISTAR; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RESPIRATION, ARTIFICIAL; SOLITARY NUCLEUS; SPLANCHNIC NERVES; UROCORTINS; VAGOTOMY;

EID: 61949269233     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01044.2008     Document Type: Article

References (46)

1. Bindslev N. A homotropic two-state model and auto-antagonism. BMC Pharmacol 4: 11-22, 2004.
2. Bittencourt JC, Vaughan J, Arias C, Rissman RA, Vale WW, Sawchenko PE. Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors. J Comp Neurol 415: 285-312, 1999.
3. Brown SN, Chitravanshi VC, Sapru HN. Cardiovascular actions of adrenocorticotropin microinjections into the nucleus tractus solitarius of the rat. Neuroscience 143: 863-874, 2006.
4. Brown SN, Chitravanshi VC, Kawabe K, Sapru HN. Microinjections of melanin concentrating hormone into the nucleus tractus solitarius of the rat elicit depressor and bradycardic responses. Neuroscience 50: 796-806, 2007.
5. Chalmers DT, Lovenberg TW, De Souza EB. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 15: 6340-6350, 1995.
6. Chen OC, Doong ML, Rivier JE, Tache Y. Intravenous urocortin II decreases blood pressure through CRF(2) receptor in rats. Regul Pept 113: 125-130, 2003.
7. Chu CP, Qiu DL, Kato K, Kunitake T, Watanabe S, Yu NS, Nakazato M, Kannan H. Central stresscopin modulates cardiovascular function through the adrenal medulla in conscious rats. Regul Pept 119: 53-59, 2004.
8. Dautzenberg FM, Hauger RL. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci 23: 71-77, 2002.
9. Dhruva A, Bhatnagar T, Sapru HN. Cardiovascular responses to microin- jections of glutamate into the nucleus tractus solitarii of unanesthetized supracollicular decerebrate rats. Brain Research 801: 88 -100, 1998.
10. Donaldson CJ, Sutton SW, Perrin MH, Corrigan AZ, Lewis KA, Rivier JE, Vaughan JM, Vale WW. Cloning and characterization of human urocortin. Endocrinology 137: 2167-2170, 1996.
11. Drolet G, Rivest S. Corticotropin-releasing hormone and its receptors; an evaluation at the transcription level in vivo. Peptides 22: 761-767, 2001.
12. Gross PM, Wall KM, Pang JJ, Shaver SW, Wainman DS. Microvascular specializations promoting rapid interstitial solute dispersion in nucleus tractus solitarius. Am J Physiol Regul Integr Comp Physiol 259: R1131-R1138, 1990.
13. Gulyas J, Rivier C, Perrin M, Koerber SC, Sutton S, Corrigan A, Lahrichi SL, Craig AG, Vale WW, Rivier J. Potent, structurally constrained agonists and competitive antagonists of corticotrophin-releasing factor. Proc Natl Acad Sci USA 92: 10575-10579, 1995.
14. Hauger RL, Grigoriadis DE, Dallman MF, Plotsky PM, Vale WW, Dautzenberg FM. International Union of Pharmacology XXXVI. Current status of the nomenclature for receptors for corticotrophin releasing factor and their ligands. Pharmacol Rev 55: 21-26, 2003.
15. Hsu SY, Hsueh AJ. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med 7: 605-611, 2001.
16. Iino K, Sasano H, Oki Y, Andoh N, Shin RW, Kitamoto T, Takahashi K, Suzuki H, Tezuka F, Yoshimi T, Nagura H. Urocortin expression in the human central nervous system. Clin Endocrinol (Oxf) 50: 107-114, 1999.
17. Jamieson PM, Li C, Kukura C, Vaughan J, Vale W. Urocortin 3 modulates the neuroendocrine stress response and is regulated in rat amygdala and hypothalamus by stress and glucocorticoids. Endocrinology 147: 4578-4588, 2006.
18. Kasamatsu K, Chitravanshi VC, Sapru HN. Depressor and bradycardic responses to microinjections of endomorphin-2 into the NTS are mediated via ionotropic glutamate receptors. Am J Physiol Regul Integr Comp Physiol 287: R715-R728, 2004.
19. Kastin AJ, Akerstrom V. Differential interactions of urocortin/corticotropinreleasing hormone peptides with the blood-brain barrier. Neuroendocrinology 75: 367-374, 2002.
20. Kozicz T, Yanaihara H, Arimura A. Distribution of urocortin-like immunoreactivity in the central nervous system of the rat. J Comp Neurol 391: 1-10, 1998.
21. Lawrence AJ, Krstew EV, Dautzenberg FM, Ruhmann A. The highly selective CRF2 receptor antagonist K41498 binds to presynaptic CRF2 receptors in rat brain. Br J Pharmacol 136: 896-904, 2002.
22. Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W, Bilezikjian L, Rivier J, Sawchenko PE, Vale WW. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl AcadSci USA98: 7570-7575, 2001.
23. Li C, Vaughan J, Sawchenko PE, Vale WW. Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression. J Neurosci 22: 991-1001, 2002.
24. Li C, Chen P, Vaughan J, Blount A, Chen A, Jamieson PM, Rivier J, Smith MS, Vale WW. Urocortin III is expressed in pancreatic beta-cells and stimulates insulin and glucagon secretion. Endocrinology 144: 3216-3224, 2003.
25. Mendelowitz D. Advances in parasympathetic control of heart rate and cardiac function. News Physiol Sci 14: 155-161, 1999.
26. Moreau JL, Kilpatrick G, Jenck F. Urocortin, a novel neuropeptide with anxiogenic-like properties. Neuroreport 8: 1697-1701, 1997.
27. Morin SM, Ling N, Liu XJ, Kahl SD, Gehlert DR. Differential distribution of urocortin- and corticotropin-releasing factor-like immunoreactivities in the rat brain. Neuroscience 92: 281-291, 1999.
28. Nakamura T, Kawabe K, Sapru HN. Cold pressor test in the rat: medullary and spinal pathways and neurotransmitters. Am J Physiol Heart Circ Physiol 295: H1780-H1787, 2008.
29. Neff RA, Mihalevich M, Mendelowitz D. Stimulation of NTS activates NMDA and non-NMDA receptors in rat cardiac vagal neurons in the nucleus ambiguus. Brain Res 792: 277-282, 1998.
30. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates (4th ed.). New York: Academic, 1986.
31. Perrin MH, Vale WW. Corticotropin releasing factor receptors and their ligand family. Ann NY Acad Sci 885: 312-328, 1999.
32. Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesch JB, Gulyas J, Rivier J, Vale WW, Sawchenko PE. Urocortin II: a member of the corticotropin releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA 98: 2843-2848, 2001.
33. Richter RM, Mulvany MJ. Comparison of hCRF and oCRF effects on cardiovascular responses after central, peripheral, and in vitro application. Peptides 16: 843-849, 1995.
34. Sanchez MM, Young LJ, Plotsky PM, Insel TR. Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain. J Comp Neurol 408: 365-377, 1999.
35. Sapru HN. Glutamate circuits in selected medullo-spinal areas regulating cardiovascular function. Clin Exp Pharmacol Physiol 29: 491-496, 2002.
36. Silva de Oliveira LC, Bonagamba LG, Machado BH. Noradrenergic inhibitory modulation in the caudal commissural NTS of the pressor response to chemoreflex activation in awake rats. Auton Neurosci 136: 63-68, 2007.
37. Spina M, Merlo-Pich E, Chan RK, Basso AM, Rivier J, Vale WW, Koob GF. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 273: 1561-1564, 1996.
38. Sved AF. GABA-mediated neural transmission in mechanisms of cardiovascular control by the NTS. In: Nucleus of the Solitary Tract, edited by Barraco IRA. Boca Raton, FL: CRC, 1994, p. 245-253.
39. Takahashi K, Totsune K, Murakami O, Saruta M, Nakabayashi M, Suzuki T, Sasano H, Shibahara S. Expression of urocortin III/stresscopin in human heart and kidney. J Clin Endocrinol Metab 89: 1897-1903, 2004.
40. Turnbull AV, Vale WW, Rivier C. Urocortin, a corticotropin- releasing factor-related mammalian peptide, inhibits edema due to thermal injury in rats. Eur J Pharmacol 303: 213-216, 1996.
41. Urbanski R, Sapru HN. Evidence for a sympathoexcitatory pathway from the nucleus tractus solitarius to the ventrolateral medullary pressor area. J Auton Nerv Syst 23: 161-174, 1988.
42. Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C, Prins GS, Perrin M, Vale W, Sawchenko PE. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428: 191-212, 2000.
43. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, Rivier J, Sawchenko PE, Vale W. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378: 287-292, 1995.
44. Venihaki M, Sakihara S, Subramanian S, Dikkes P, Weninger SC, Liapakis G, Graf T, Majzoub JA. Urocortin III, a brain neuropeptide of the corticotropinreleasing hormone family: modulation by stress and attenuation of some anxietylike behaviours. J Neuroendocrinol 16: 411-422, 2004.
45. Yamamoto H, Maeda T, Fujimura M, Fujimiya M. Urocortin-like immunoreactivity in the substantia nigra, ventral tegmental area and Edinger-Westphal nucleus of rat. Neurosci Lett 243: 21-24, 1998.
46. Yamazaki T, Waki H, Kohsaka A, Nakamura T, Cui H, Yukawa K, Maeda M. Microinjection of urocortin into the rat nucleus tractus solitarii decreases arterial blood pressure. Auton Neurosci 142: 51-54, 2008.